BFC Planning’s Dogwood Therapeutics DWTX Stock Holding History
Bought
Maintained
Sold
Other funds holding DWTX
BFC Planning's DWTX Position: Q3 2026 in Review
BFC Planning held its Dogwood Therapeutics (DWTX) position steady in Q3 2026 at 20 shares worth $27. The position accounts for ﹤0.01% of the portfolio, ranked #3437.
BFC Planning first reported a position in DWTX in Q3 2024 and has held it in 9 quarters since. The position peaked at $308 in Q3 2025. 15 funds tracked by Wall St. Rank hold DWTX as of Q3 2026.
- BFC Planning held 20 shares of Dogwood Therapeutics worth $27 as of Q3 2026.
- BFC Planning left its Dogwood Therapeutics share count unchanged in Q3 2026.
- Dogwood Therapeutics made up ﹤0.01% of BFC Planning's portfolio in Q3 2026, its #3437 holding.
- BFC Planning first reported a position in Dogwood Therapeutics in Q3 2024 and has held it in 9 quarters since.
- BFC Planning's Dogwood Therapeutics position peaked at $308 in Q3 2025.
- 15 funds tracked by Wall St. Rank held Dogwood Therapeutics as of Q3 2026.
Based on BFC Planning's 13F filing for Q3 2026, filed 13 Nov 2026.